Anisodamine has been investigated for the treatment of Intestinal Diseases.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Ceritinib | Anisodamine may increase the bradycardic activities of Ceritinib. |
| Ivabradine | Anisodamine may increase the bradycardic activities of Ivabradine. |
| Ruxolitinib | Ruxolitinib may increase the bradycardic activities of Anisodamine. |
| Remikiren | Anisodamine may decrease the antihypertensive activities of Remikiren. |
| Torasemide | Anisodamine may decrease the antihypertensive activities of Torasemide. |
| Chlorthalidone | Anisodamine may decrease the antihypertensive activities of Chlorthalidone. |
| Nitroprusside | Anisodamine may decrease the antihypertensive activities of Nitroprusside. |
| Minoxidil | Anisodamine may decrease the antihypertensive activities of Minoxidil. |
| Metolazone | Anisodamine may decrease the antihypertensive activities of Metolazone. |
| Bosentan | Anisodamine may decrease the antihypertensive activities of Bosentan. |
| Cyclothiazide | Anisodamine may decrease the antihypertensive activities of Cyclothiazide. |
| Candoxatril | Anisodamine may decrease the antihypertensive activities of Candoxatril. |
| Mecamylamine | Anisodamine may decrease the antihypertensive activities of Mecamylamine. |
| Nitroglycerin | Anisodamine may decrease the antihypertensive activities of Nitroglycerin. |
| Metyrosine | Anisodamine may decrease the antihypertensive activities of Metyrosine. |
| Hydroflumethiazide | Anisodamine may decrease the antihypertensive activities of Hydroflumethiazide. |
| Cryptenamine | Anisodamine may decrease the antihypertensive activities of Cryptenamine. |
| Fenoldopam | Anisodamine may decrease the antihypertensive activities of Fenoldopam. |
| Tadalafil | Anisodamine may decrease the antihypertensive activities of Tadalafil. |
| Chlorothiazide | Anisodamine may decrease the antihypertensive activities of Chlorothiazide. |
| Trichlormethiazide | Anisodamine may decrease the antihypertensive activities of Trichlormethiazide. |
| Pentolinium | Anisodamine may decrease the antihypertensive activities of Pentolinium. |
| Trimethaphan | Anisodamine may decrease the antihypertensive activities of Trimethaphan. |
| Diazoxide | Anisodamine may decrease the antihypertensive activities of Diazoxide. |
| Epoprostenol | Anisodamine may decrease the antihypertensive activities of Epoprostenol. |
| Hydralazine | Anisodamine may decrease the antihypertensive activities of Hydralazine. |
| Polythiazide | Anisodamine may decrease the antihypertensive activities of Polythiazide. |
| Tienilic acid | Anisodamine may decrease the antihypertensive activities of Tienilic acid. |
| Sitaxentan | Anisodamine may decrease the antihypertensive activities of Sitaxentan. |
| Ambrisentan | Anisodamine may decrease the antihypertensive activities of Ambrisentan. |
| Diethylnorspermine | Anisodamine may decrease the antihypertensive activities of Diethylnorspermine. |
| Pinacidil | Anisodamine may decrease the antihypertensive activities of Pinacidil. |
| Riociguat | Anisodamine may decrease the antihypertensive activities of Riociguat. |
| Macitentan | Anisodamine may decrease the antihypertensive activities of Macitentan. |
| Hexamethonium | Anisodamine may decrease the antihypertensive activities of Hexamethonium. |
| Rauwolfia serpentina root | Anisodamine may decrease the antihypertensive activities of Rauwolfia serpentina root. |
| Selexipag | Anisodamine may decrease the antihypertensive activities of Selexipag. |
| Angiotensin 1-7 | Anisodamine may decrease the antihypertensive activities of Angiotensin 1-7. |
| BQ-123 | Anisodamine may decrease the antihypertensive activities of BQ-123. |
| Dihydralazine | Anisodamine may decrease the antihypertensive activities of Dihydralazine. |
| Guanoxan | Anisodamine may decrease the antihypertensive activities of Guanoxan. |
| Vincamine | Anisodamine may decrease the antihypertensive activities of Vincamine. |
| Linsidomine | Anisodamine may decrease the antihypertensive activities of Linsidomine. |
| Guanoxabenz | Anisodamine may decrease the antihypertensive activities of Guanoxabenz. |
| Tolonidine | Anisodamine may decrease the antihypertensive activities of Tolonidine. |
| Endralazine | Anisodamine may decrease the antihypertensive activities of Endralazine. |
| Cadralazine | Anisodamine may decrease the antihypertensive activities of Cadralazine. |
| Cyclopenthiazide | Anisodamine may decrease the antihypertensive activities of Cyclopenthiazide. |
| Bietaserpine | Anisodamine may decrease the antihypertensive activities of Bietaserpine. |
| Guanazodine | Anisodamine may decrease the antihypertensive activities of Guanazodine. |
| Methoserpidine | Anisodamine may decrease the antihypertensive activities of Methoserpidine. |
| Guanoclor | Anisodamine may decrease the antihypertensive activities of Guanoclor. |
| Muzolimine | Anisodamine may decrease the antihypertensive activities of Muzolimine. |
| Xipamide | Anisodamine may decrease the antihypertensive activities of Xipamide. |
| Tocopherylquinone | Anisodamine may decrease the antihypertensive activities of Tocopherylquinone. |
| Furosemide | Anisodamine may decrease the antihypertensive activities of Furosemide. |
| Ramipril | Anisodamine may decrease the antihypertensive activities of Ramipril. |
| Perindopril | Anisodamine may decrease the antihypertensive activities of Perindopril. |
| Levamlodipine | The risk or severity of bradycardia can be increased when Levamlodipine is combined with Anisodamine. |
| Buthiazide | Anisodamine may decrease the antihypertensive activities of Buthiazide. |
| Amiodarone | The therapeutic efficacy of Anisodamine can be increased when used in combination with Amiodarone. |
| Bupivacaine | The serum concentration of Bupivacaine can be increased when it is combined with Anisodamine. |
| Dipyridamole | Dipyridamole may increase the bradycardic activities of Anisodamine. |
| Disopyramide | Disopyramide may increase the bradycardic activities of Anisodamine. |
| Dronedarone | Dronedarone may increase the bradycardic activities of Anisodamine. |
| Fingolimod | Anisodamine may increase the bradycardic activities of Fingolimod. |
| Floctafenine | The risk or severity of adverse effects can be increased when Anisodamine is combined with Floctafenine. |
| Mepivacaine | The serum concentration of Mepivacaine can be increased when it is combined with Anisodamine. |
| Methacholine | Anisodamine may increase the bronchoconstrictory activities of Methacholine. |
| Midodrine | The therapeutic efficacy of Midodrine can be decreased when used in combination with Anisodamine. |
| Nifedipine | The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Anisodamine. |
| Propafenone | The risk or severity of adverse effects can be increased when Propafenone is combined with Anisodamine. |
| Regorafenib | Regorafenib may increase the bradycardic activities of Anisodamine. |
| Reserpine | Reserpine may increase the hypotensive activities of Anisodamine. |
| Deserpidine | Deserpidine may increase the hypotensive activities of Anisodamine. |
| Guanethidine | Guanethidine may increase the hypotensive activities of Anisodamine. |
| Rivastigmine | Anisodamine may increase the bradycardic activities of Rivastigmine. |
| Desmopressin | The risk or severity of hypertension can be increased when Desmopressin is combined with Anisodamine. |
| Zolmitriptan | The risk or severity of hypertension can be increased when Zolmitriptan is combined with Anisodamine. |
| Methylphenidate | The risk or severity of hypertension can be increased when Methylphenidate is combined with Anisodamine. |
| Doxapram | The risk or severity of hypertension can be increased when Doxapram is combined with Anisodamine. |
| Linezolid | The risk or severity of hypertension can be increased when Linezolid is combined with Anisodamine. |
| Furazolidone | The risk or severity of hypertension can be increased when Furazolidone is combined with Anisodamine. |
| Sumatriptan | The risk or severity of hypertension can be increased when Sumatriptan is combined with Anisodamine. |
| Phenmetrazine | The risk or severity of hypertension can be increased when Phenmetrazine is combined with Anisodamine. |
| Naratriptan | The risk or severity of hypertension can be increased when Naratriptan is combined with Anisodamine. |
| Rizatriptan | The risk or severity of hypertension can be increased when Rizatriptan is combined with Anisodamine. |
| Dopamine | The risk or severity of hypertension can be increased when Dopamine is combined with Anisodamine. |
| Frovatriptan | The risk or severity of hypertension can be increased when Frovatriptan is combined with Anisodamine. |
| Dutasteride | The risk or severity of hypertension can be increased when Dutasteride is combined with Anisodamine. |
| Halothane | The risk or severity of hypertension can be increased when Halothane is combined with Anisodamine. |
| Finasteride | The risk or severity of hypertension can be increased when Finasteride is combined with Anisodamine. |
| Isocarboxazid | The risk or severity of hypertension can be increased when Isocarboxazid is combined with Anisodamine. |
| Rasagiline | The risk or severity of hypertension can be increased when Rasagiline is combined with Anisodamine. |
| Pargyline | Anisodamine may decrease the antihypertensive activities of Pargyline. |
| Epicaptopril | The risk or severity of hypertension can be increased when Epicaptopril is combined with Anisodamine. |
| Clorgiline | The risk or severity of hypertension can be increased when Clorgiline is combined with Anisodamine. |
| 1-benzylimidazole | The risk or severity of hypertension can be increased when 1-benzylimidazole is combined with Anisodamine. |
| Nialamide | The risk or severity of hypertension can be increased when Nialamide is combined with Anisodamine. |
| Flibanserin | The risk or severity of hypertension can be increased when Flibanserin is combined with Anisodamine. |